Article (Scientific journals)
Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice.
Gregoire-Gauthier, Joëlle; Fontaine, francois; Benchimol, Lionel et al.
2015In Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 21 (5), p. 821-8
Peer reviewed
 

Files


Full Text
PIIS1083879115000245.pdf
Publisher postprint (1.03 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Animals; Disease Models, Animal; Graft vs Host Disease/chemically induced/genetics/immunology/pathology; Heterografts; Humans; K562 Cells; Killer Cells, Natural/immunology/pathology; Leukocytes, Mononuclear/pathology/transplantation; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Graft-versus-host disease; Intravenous immunoglobulin; NSG mice; Natural killer cells; Xenogeneic mouse model
Abstract :
[en] Although clinical studies have yet to demonstrate clearly the use of intravenous immunoglobulin (IVIG) for prevention of graft-versus-host disease (GVHD), their effective use in a xenogeneic mouse model has been demonstrated. We aimed to determine the mechanism of action by which IVIG contributes to GVHD prevention in a xenogeneic mouse model. NOD/LtSz-scidIL2rg(-/-) (NSG) mice were used for our xenogeneic mouse model of GVHD. Sublethally irradiated NSG mice were injected with human peripheral blood mononuclear cells (huPBMCs) and treated weekly with PBS or 50 mg IVIG. Incidence of GVHD and survival were noted, along with analysis of cell subsets proliferation in the peripheral blood. Weekly IVIG treatment resulted in a robust and consistent proliferation of human natural killer cells that were activated, as demonstrated by their cytotoxicity against K562 target cells. IVIG treatment did not inhibit GVHD when huPBMCs were depleted in natural killer (NK) cells, strongly suggesting that this NK cell expansion was required for the IVIG-mediated prevention of GVHD in our mouse model. Moreover, inhibition of T cell activation by either cyclosporine A (CsA) or monoclonal antihuman CD3 antibodies abolished the IVIG-induced NK cell expansion. In conclusion, IVIG treatment induces NK cell proliferation, which is essential for IVIG-mediated protection of GVHD in our mouse model. Furthermore, activated T cells are mandatory for effective IVIG-induced NK cell proliferation. These results shed light on a new mechanism of action of IVIG and could explain why the efficacy of IVIG in preventing GVHD in a clinical setting, where patients receive CsA, has never been undoubtedly demonstrated.
Disciplines :
Hematology
Author, co-author :
Gregoire-Gauthier, Joëlle
Fontaine, francois;  CHU sainte justine > Immuno-pédiatrie
Benchimol, Lionel ;  Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service d'ORL, d'audiophonologie et de chir. cervico-faciale
Nicoletti, Simon
Selleri, Silvia
Dieng, Mame Massar
Haddad, Elie
Language :
English
Title :
Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice.
Publication date :
2015
Journal title :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN :
1083-8791
eISSN :
1523-6536
Volume :
21
Issue :
5
Pages :
821-8
Peer reviewed :
Peer reviewed
Commentary :
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Available on ORBi :
since 06 June 2020

Statistics


Number of views
47 (4 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
11
Scopus citations®
without self-citations
11
OpenCitations
 
9

Bibliography


Similar publications



Contact ORBi